Search All Funding News

Filter NIAID Funding News by year:
2024 | 2023 | 2022

37 Results

Take Note of Reissued Investigator-Initiated Clinical Trial NOFOs

Funding News Edition: February 7, 2024

The NIAID Clinical Trial Implementation Cooperative Agreement notice of funding opportunity (NOFO) is designed for high-risk trials. The NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement NOFO allows small business concerns to proposed investigator-initiated clinical trials.

A Summary of Outcomes from Our September Advisory Council Meeting

Funding News Edition: October 4, 2023

NIAID Acting Director Dr. Hugh Auchincloss provided remarks on the Institute’s administrative, budget, and scientific news. He was followed by guest speaker Dr. Ted Pierson, Director of NIAID’s Vaccine Research Center, who discussed recent scientific advances and ongoing research priorities.

Distribution of Applications by Career Stage Held Steady Through the Pandemic

Funding News Edition: August 16, 2023

The most recent analysis found a continual increase in the proportion of applications designating either female or underrepresented minority early-stage investigators both before and after the pandemic.

NIAID Wants Your Feedback on Strategic Plan to Accelerate Tuberculosis Research

Funding News Edition: July 6, 2023

Our revised Strategic Plan is structured around five strategic priorities that capitalize on recent advances in the field; each critical to the development and evaluation of knowledge and tools needed to end tuberculosis globally.

Publicize Your Research Findings Through NIAID

Funding News Edition: July 6, 2023

When you’re ready to publicize your scientific discoveries, let NIAID help spread the word. Through a variety of communication vehicles, our News and Science Writing Branch highlights the work of NIAID-funded researchers.

Highlights from June’s Advisory Council Meeting

Funding News Edition: June 21, 2023

NIAID Acting Director Dr. Hugh Auchincloss discussed administrative, budget, and legislative updates, as well as recent scientific findings. Then Dr. Steven Holland, Director of NIAID’s Division of Intramural Research, described key research accomplishments at our intramural laboratories.

A Rule Change for Preliminary Data as Post-Submission Materials

Funding News Edition: April 19, 2023

NIH will allow applicants to submit preliminary data as post-submission materials for new applications (Type 1) if the notice of funding opportunity uses the R01, R03, or R21 activity codes and allows preliminary data.

Provide Feedback to Help NIH Evaluate Postdoctoral Research Training

Funding News Edition: March 1, 2023

Share your thoughts on the roles and responsibilities of academic postdocs, including challenges in recruitment, retention, and quality of life of postdoctoral trainees.

Reviewing NIAID’s Application and Award Counts for FY 2022

Funding News Edition: February 15, 2023

We share the number of R01-equivalent and R21 applications that NIAID received in the previous fiscal year (FY) as well as how many awards NIAID made in turn.

Administrative Supplement Supports Research Testing on Gender Measurement

Funding News Edition: February 15, 2023

The health conditions of interest to NIAID impact the health of sexual minority and majority populations, and the Institute endorses meaningful sexual orientation and gender identity measurement in research, clinical care, and administrative settings.

Summary of January 2023 Advisory Council Meeting

Funding News Edition: February 15, 2023

NIAID Acting Director Dr. Hugh Auchincloss provided updates on HIV/AIDS, malaria, Ebola, a promising Marburg vaccine, universal flu vaccine efforts, non-viral asthma attacks, monoclonal antibodies to target Epstein-Barr virus, and human antibody response to vaccinations.

December’s ACD Meeting—Featuring Bill Gates and Dr. Anthony Fauci

Funding News Edition: February 1, 2023

NIH’s Advisory Committee to the Director (ACD) provides recommendations on program development, resource allocation, NIH administrative regulation, and other aspects of NIH policy.

Four Research Areas Comprise NIAID’s 2023 Omnibus Contract Solicitation

Funding News Edition: February 1, 2023

Successful offerors will help advance the research and development of promising candidate vaccines, therapeutics, and diagnostics for biodefense, emerging infectious diseases, and pandemic preparedness.

Provide Input on Clinical Research Infrastructure and Emergency Clinical Trials

Funding News Edition: December 7, 2022

Recognizing lessons learned during the COVID-19 pandemic, a new request for information solicits feedback on how to strengthen the capacity of clinical trial infrastructure and emergency trials.

Apply to Integrated Preclinical/Clinical AIDS Vaccine Development Program

Funding News Edition: November 16, 2022

NIAID's initiative will fund a multidisciplinary consortium with expertise in vaccinology, animal models, molecular biology, cell biology, immunology, manufacturing, and adjuvant biology.

A Summary of September’s Advisory Council Meeting

Funding News Edition: October 5, 2022

NIAID Director Dr. Anthony Fauci said, "It has been an enormous pleasure and privilege of my job to have worked with the many extraordinarily intelligent and talented individuals who have served Council over the years.” 

Novel R01 Seeks New and “At-Risk” Investigators from Diverse Backgrounds

Funding News Edition: October 5, 2022

Through this new initiative, eligible individuals are invited to submit investigator-initiated research project grant applications within the scope of NIAID's scientific areas of focus.

Administrative Supplements for Women’s Health Research in U3 Populations

Funding News Edition: October 5, 2022

The Notice of Special Interest encourages rigorous interdisciplinary research on the complex intersection of women’s health, sex and gender, and social determinants of health.

Pandemic Exception Ends for Semiannual Inspection of Animal Facilities

Funding News Edition: September 21, 2022

Begining October 1, 2022, all Assured institutions, including those with expiring waivers, must conduct semiannual animal facility inspections as scheduled and required by Public Health Service policy.

Recapping June’s Advisory Council Meeting

Funding News Edition: July 7, 2022

At the 201st meeting of NIAID’s Advisory Council, NIAID Director Dr. Anthony Fauci gave remarks on NIAID’s budget, outreach activities, scientific priorities, and research outcomes.

June 2022 ACD Meeting—ARPA-H, COVID-19, UNITE, and Data Sharing

Funding News Edition: July 7, 2022

NIH’s Advisory Committee to the Director (ACD) provides recommendations on program development, resource allocation, NIH administrative regulation, and other aspects of NIH policy.

Reference NIH’s Biomedical Research and Development Price Index

Funding News Edition: June 1, 2022

In general terms, the Biomedical Research and Development Price Index indicates how much money is needed to purchase the same amount of biomedical research as the year before.

COVID-19 Exception—Post-Submission Materials for January 2023 Council Rounds

Funding News Edition: May 18, 2022

An exception to allow applicants to send one page with preliminary data as post-submission materials will remain in effect for applications submitted for the January 2023 Council rounds.

Contact Us

Email us at deaweb@niaid.nih.gov for help navigating NIAID’s grant and contract policies and procedures.